Hatch-Waxman Improvement Act of 2022
Summary
Hatch-Waxman Improvement Act of 2022 This bill extends through FY2026 provisions that establish a period of market exclusivity for certain new drugs with single enantiomers (i.e., one of a pair of molecules that are mirror images of one another).
Bill status
in committee
1 of 4 stages cleared
Introduction
Jun 2022
Committee Review
Floor Vote
President
Introduced Jun 13, 2022
Last action Jun 13, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Jun 13, 2022
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Jun 13, 2022
Introduced
Introduced in Senate
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Roger Marshall
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about S 4378
Scope: US
Hi! I can help you understand S 4378. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline